177 related articles for article (PubMed ID: 8120653)
1. Vitamin E deficiency intensifies the myocardial injury of coxsackievirus B3 infection of mice.
Beck MA; Kolbeck PC; Rohr LH; Shi Q; Morris VC; Levander OA
J Nutr; 1994 Mar; 124(3):345-58. PubMed ID: 8120653
[TBL] [Abstract][Full Text] [Related]
2. Increased virulence of a human enterovirus (coxsackievirus B3) in selenium-deficient mice.
Beck MA; Kolbeck PC; Shi Q; Rohr LH; Morris VC; Levander OA
J Infect Dis; 1994 Aug; 170(2):351-7. PubMed ID: 8035022
[TBL] [Abstract][Full Text] [Related]
3. Benign human enterovirus becomes virulent in selenium-deficient mice.
Beck MA; Kolbeck PC; Rohr LH; Shi Q; Morris VC; Levander OA
J Med Virol; 1994 Jun; 43(2):166-70. PubMed ID: 8083665
[TBL] [Abstract][Full Text] [Related]
4. Copper deficiency increases the virulence of amyocarditic and myocarditic strains of coxsackievirus B3 in mice.
Smith AD; Botero S; Levander OA
J Nutr; 2008 May; 138(5):849-55. PubMed ID: 18424590
[TBL] [Abstract][Full Text] [Related]
5. Benign coxsackievirus damages heart muscle in iron-loaded vitamin E-deficient mice.
Beck MA; Shi Q; Morris VC; Levander OA
Free Radic Biol Med; 2005 Jan; 38(1):112-6. PubMed ID: 15589379
[TBL] [Abstract][Full Text] [Related]
6. Interacting nutritional and infectious etiologies of Keshan disease. Insights from coxsackie virus B-induced myocarditis in mice deficient in selenium or vitamin E.
Levander OA; Beck MA
Biol Trace Elem Res; 1997 Jan; 56(1):5-21. PubMed ID: 9152508
[TBL] [Abstract][Full Text] [Related]
7. Coxsackievirus B3-resistant mice become susceptible in Se/vitamin E deficiency.
Beck MA; Williams-Toone D; Levander OA
Free Radic Biol Med; 2003 May; 34(10):1263-70. PubMed ID: 12726914
[TBL] [Abstract][Full Text] [Related]
8. Persistence of replicating coxsackievirus B3 in the athymic murine heart is associated with development of myocarditic lesions.
Sato S; Tsutsumi R; Burke A; Carlson G; Porro V; Seko Y; Okumura K; Kawana R; Virmani R
J Gen Virol; 1994 Nov; 75 ( Pt 11)():2911-24. PubMed ID: 7964602
[TBL] [Abstract][Full Text] [Related]
9. Effect of gold(I) compounds on the virulence of an amyocarditic strain of coxsackievirus B3.
Smith AD; South PK; Levander OA
Biol Trace Elem Res; 2001; 84(1-3):67-80. PubMed ID: 11817697
[TBL] [Abstract][Full Text] [Related]
10. Selenium and viral virulence.
Levander OA; Beck MA
Br Med Bull; 1999; 55(3):528-33. PubMed ID: 10746343
[TBL] [Abstract][Full Text] [Related]
11. Rapid genomic evolution of a non-virulent coxsackievirus B3 in selenium-deficient mice results in selection of identical virulent isolates.
Beck MA; Shi Q; Morris VC; Levander OA
Nat Med; 1995 May; 1(5):433-6. PubMed ID: 7585090
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of Histone Deacetylase Activity Aggravates Coxsackievirus B3-Induced Myocarditis by Promoting Viral Replication and Myocardial Apoptosis.
Zhou L; He X; Gao B; Xiong S
J Virol; 2015 Oct; 89(20):10512-23. PubMed ID: 26269170
[TBL] [Abstract][Full Text] [Related]
13. Adiponectin promotes coxsackievirus B3 myocarditis by suppression of acute anti-viral immune responses.
Jenke A; Holzhauser L; Löbel M; Savvatis K; Wilk S; Weithäuser A; Pinkert S; Tschöpe C; Klingel K; Poller W; Scheibenbogen C; Schultheiss HP; Skurk C
Basic Res Cardiol; 2014 May; 109(3):408. PubMed ID: 24691762
[TBL] [Abstract][Full Text] [Related]
14. An aged host promotes the evolution of avirulent coxsackievirus into a virulent strain.
Gay RT; Belisle S; Beck MA; Meydani SN
Proc Natl Acad Sci U S A; 2006 Sep; 103(37):13825-30. PubMed ID: 16950876
[TBL] [Abstract][Full Text] [Related]
15. Treatment of coxsackievirus-B3-infected BALB/c mice with the soluble coxsackie adenovirus receptor CAR4/7 aggravates cardiac injury.
Dörner A; Grunert HP; Lindig V; Chandrasekharan K; Fechner H; Knowlton KU; Isik A; Pauschinger M; Zeichhardt H; Schultheiss HP
J Mol Med (Berl); 2006 Oct; 84(10):842-51. PubMed ID: 16924471
[TBL] [Abstract][Full Text] [Related]
16. Colchicine aggravates coxsackievirus B3 infection in mice.
Smilde BJ; Woudstra L; Fong Hing G; Wouters D; Zeerleder S; Murk JL; van Ham M; Heymans S; Juffermans LJ; van Rossum AC; Niessen HW; Krijnen PA; Emmens RW
Int J Cardiol; 2016 Aug; 216():58-65. PubMed ID: 27140338
[TBL] [Abstract][Full Text] [Related]
17. Cyclosporine A Treatment Inhibits Abcc6-Dependent Cardiac Necrosis and Calcification following Coxsackievirus B3 Infection in Mice.
Marton J; Albert D; Wiltshire SA; Park R; Bergen A; Qureshi S; Malo D; Burelle Y; Vidal SM
PLoS One; 2015; 10(9):e0138222. PubMed ID: 26375467
[TBL] [Abstract][Full Text] [Related]
18. CX3CR1 knockout aggravates Coxsackievirus B3-induced myocarditis.
Müller I; Pappritz K; Savvatis K; Puhl K; Dong F; El-Shafeey M; Hamdani N; Hamann I; Noutsias M; Infante-Duarte C; Linke WA; Van Linthout S; Tschöpe C
PLoS One; 2017; 12(8):e0182643. PubMed ID: 28800592
[TBL] [Abstract][Full Text] [Related]
19. Successive infection of coxsackievirus B3 and encephalomyocarditis virus: an animal model of chronic myocarditis.
Okada I; Matsumori A; Tomioka N; Kawai C
J Pathol; 1992 Jul; 167(3):341-7. PubMed ID: 1325552
[TBL] [Abstract][Full Text] [Related]
20. Genomic determinants of cardiovirulence in coxsackievirus B3 clinical isolates: localization to the 5' nontranslated region.
Dunn JJ; Chapman NM; Tracy S; Romero JR
J Virol; 2000 May; 74(10):4787-94. PubMed ID: 10775617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
